Calijan, Ranesa .
HRN: 09-43-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2024
CEFUROXIME 500MG (TAB)
12/10/2024
12/16/2024
ORAL
500mg
BID
S/p Endometrial Biopsy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes